TROY DAVIS: Open Payments
NPI 1790793685 · MISSOULA, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$710 in 26 payments from 11 companies in 2025. Trend: 2023 $2,124 · 2024 $1,286 · 2025 $710
Food & beverage: $710
| Company | Payments | Amount |
|---|---|---|
| BioWound Solutions, Inc. | 2 | $144 |
| Incyte Corporation | 4 | $97 |
| Amgen Inc. | 4 | $80 |
| ABBVIE INC. | 3 | $63 |
| Organon LLC | 3 | $61 |
| Novartis Pharmaceuticals Corporation | 3 | $59 |
| Exact Sciences Corporation | 1 | $49 |
| Lilly USA, LLC | 2 | $47 |
| ACADIA Pharmaceuticals Inc | 1 | $43 |
| UCB, Inc. | 2 | $36 |
Products named: bio-ConneKt, OPZELURA, Otezla, Cologuard Collection Kit, DAYBUE, VTAMA, COSENTYX, Bimzelx.
Industry payments across MT — which companies pay providers there.
